Clinical Trials Logo

Atherosclerosis clinical trials

View clinical trials related to Atherosclerosis.

Filter by:

NCT ID: NCT00925561 Completed - Atherosclerosis Clinical Trials

Examining the Genetic Predictors of Coronary Artery Calcification in African Americans

Start date: January 2009
Phase: N/A
Study type: Observational

Coronary artery disease (CAD) is an important health concern for African Americans, who are diagnosed with CAD at high rates. Coronary artery calcification, which is characterized by calcium deposits in the coronary arteries, is a contributing factor to CAD. This study will examine the possible genetic causes of coronary artery calcification in African Americans.

NCT ID: NCT00921089 Completed - Clinical trials for Cardiovascular Diseases

Vascular Calcification, Inflammation and Coronary Flow Velocity in Hemodialysis Patients

Start date: April 2008
Phase: N/A
Study type: Observational

The aim of this cross-sectional study is to determine the correlation of coronary artery calcification as measured by electron-beam computerized tomography and coronary flow reserve measured by trans-thoracic Doppler echocardiography in hemodialysis patients. The investigators also assessed the carotid artery parameters by measuring intima media thickness that can accurately describe the process of arterial wall changes due to atherosclerosis. Possible association of coronary flow reserve with inflammation and arterial calcification in hemodialysis patients was also evaluated.

NCT ID: NCT00921011 Completed - Atherosclerosis Clinical Trials

Longitudinal Study in Perimenopausal Women With Risk Factors for Atherosclerosis

Start date: May 2009
Phase:
Study type: Observational

The study hypothesis (or theory) is that monthly loss of iron before menopause may reduce women's risk of hardening of the arteries, or atherosclerosis. This study uses noninvasive, noncontrast magnetic resonance imaging (MRI) of arteries in women entering menopause. This will help to determine if there is a correlation between iron accumulation and hardening of the arteries. In addition, blood levels of hormones will be measured to help show differences due to hormone levels vs. iron accumulation.

NCT ID: NCT00918541 Completed - Atherosclerosis Clinical Trials

Natural History of Atherosclerosis

Start date: January 2007
Phase: N/A
Study type: Observational

20 patients will be recruited. The aim of the study is to determine the natural progression of atherosclerotic disease.

NCT ID: NCT00911976 Completed - Atherosclerosis Clinical Trials

Study of the Xience V Everolimus-eluting Stent in Saphenous Vein Graft Lesions

SOS-Xience V
Start date: May 2009
Phase: Phase 4
Study type: Interventional

The specific aim of the SOS-Xience V study is to examine the 12-month incidence of binary angiographic in-stent restenosis after implantation of the Xience V stent in aortocoronary saphenous vein bypass graft lesions.

NCT ID: NCT00908297 Completed - Clinical trials for Cardiovascular Disease

Safety and Tolerability of Coenzyme Q10 in Hemodialysis Patients

Start date: February 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the safety and tolerability of the dietary supplement Coenzyme Q10 in hemodialysis patients.

NCT ID: NCT00905671 Completed - Clinical trials for Coronary Artery Disease

Intravascular Near Infrared Spectroscopy (NIRS) Bifurcation - Lipid Core Plaque Shift Study

Start date: June 2009
Phase: Phase 4
Study type: Interventional

This pilot study is going to examine the hypothesis that in coronary arteries, soft lesions that contain lipid cores, but are not calcified or fibrotic and are located in proximity to side branches, are associated with side branch compromise as a result of plaque shift during angioplasty and stenting. Plaque characteristics will be detected by intravascular near infrared spectroscopy (NIRS).

NCT ID: NCT00901446 Completed - Clinical trials for Coronary Artery Disease

Study of Near Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) Combination Coronary Catheter

SAVOIR
Start date: May 2009
Phase: N/A
Study type: Observational

This study is designed to evaluate the technical performance and clinical handling of a coronary catheter that includes two imaging techniques. The catheter being evaluated performs near infrared spectroscopy and ultrasound imaging of the coronary arteries. Near infrared spectroscopy is used to identify lipid or cholesterol deposits in the vessel wall and the ultrasound component provides structural information about the vessel. Combining multiple imaging techniques into a single catheter can reduce the total number of catheters required during treatment and the overall duration of cardiac catheterization. Both of these results may lead to safer procedures.

NCT ID: NCT00886704 Completed - Atherosclerosis Clinical Trials

Omega-3 Fatty Acids, the Omega-3 Index, and Atherosclerosis

Start date: April 2009
Phase: N/A
Study type: Interventional

An increase in intake of omega-3 fatty acids should increase the Omega-3 Index. Current evidence indicates that this may lead to a reduction in risk for sudden cardiac death and atherosclerotic diseases like myocardial infarction. The aim of the study is to investigate, how supplementing a convenience drink with omega-3 fatty acids influences the Omega-3 Index, as compared to an unsupplemented matching convenience drink. Palatability and safety of the drink are also to be assessed.

NCT ID: NCT00880178 Completed - Clinical trials for Cardiovascular Diseases

Plaque Inflammation and Dysfunctional HDL in AIM-HIGH

HDL Proteomics
Start date: May 2008
Phase:
Study type: Observational

Coronary heart disease (CHD) is a serious health concern that affects millions of people in the United States. It is usually caused by atherosclerosis—a condition that occurs when fatty material and plaque build up on the walls of the arteries that supply blood and oxygen to the heart, causing the arteries to narrow. As the arteries narrow, blood flow to the heart can slow down or stop, which can cause chest pain, shortness of breath, heart attack, or heart failure. Another component of CHD events involves inflammatory changes that result in structural breakdown of atherosclerotic plaques. Adding niacin to statin medications may be an effective way to block inflammation in the atherosclerotic plaques. This study will examine magnetic resonance imaging (MRI) images and blood samples of participants in the AIM-HIGH study who are taking niacin plus statins or statins alone to determine the effect of these medications on inflammation in atherosclerotic plaques.